[Translation] A single-center, randomized, open-label, single-dose, fasting and postprandial, two-formulation, two-sequence, four-period, fully repeated crossover bioequivalence study of sacubitril-valsartan sodium tablets in healthy adult Chinese subjects
主要目的:考察单次口服(空腹/餐后)受试制剂沙库巴曲缬沙坦钠片【规格:以沙库巴曲缬沙坦计200mg(沙库巴曲97mg/缬沙坦103mg)】与参比制剂【商品名:诺欣妥,规格:以沙库巴曲缬沙坦计200mg(沙库巴曲97mg/缬沙坦103mg)】在中国健康人体的相对生物利用度,分析两种制剂的药代动力学参数,评价两制剂的生物等效性,为该药的申报及临床用药提供参考依据。
次要目的:评价单次口服(空腹/餐后)受试制剂和参比制剂在中国成年健康受试者中的安全性。
[Translation] Primary objective: To investigate the relative bioavailability of a single oral (fasting/postprandial) test preparation of sacubitril-valsartan sodium tablets [Specification: 200 mg based on sacubitril-valsartan (sacubitril 97 mg/valsartan 103 mg)] and a reference preparation [Trade name: Nusintuo, Specification: 200 mg based on sacubitril-valsartan (sacubitril 97 mg/valsartan 103 mg)] in healthy Chinese subjects, analyze the pharmacokinetic parameters of the two preparations, evaluate the bioequivalence of the two preparations, and provide a reference for the application and clinical use of the drug.
Secondary objective: To evaluate the safety of a single oral (fasting/postprandial) test preparation and reference preparation in healthy Chinese adult subjects.